Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 6/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.37 |
| ▸ | POLA1 | P09884 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 5/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK7 | P50613 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | CCNH | P51946 | 1/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.33 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.32 |
| ▸ | MAP3K6 | O95382 | 1/20 | 0.32 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3578267 | 0.82 | ALDH1A1 (0.53) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL31058752 | 0.79 | KDM4E (0.50) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL4969622 | 0.76 | KDM4E (0.38) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL2640836 | 0.74 | ALDH1A1 (0.53) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL375956 | 0.72 | ALDH1A1 (0.59) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL1398871 | 0.72 | ALDH1A1 (0.53) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL7165321 | 0.71 | PDPK1 (0.53) | CDK2CDK1CCNB1CCNA2CCNA1 | |
| Ammonia Solution, Strong SCHEMBL27309824 | 0.71 | ALDH1A1 (0.57) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL7943075 | 0.68 | KDM4E (0.41) | KDM4EALDH1A1CDK2RXFP1PAK1 | |
| SCHEMBL30020945 | 0.68 | ALDH1A1 (0.49) | KDM4EALDH1A1CDK2RXFP1PAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2131848-A2 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALY ACTIVE MOLECULES | Merck & Co., Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008103276-A2 | COMPOSITIONS AND METHODS FOR POTENTIATED ACTIVITY OF BIOLOGICALY ACTIVE MOLECULES | MERCK & CO., INC. (US) | 2008-08-28 | — | — | WO | disclosed |
| EP-1951873-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF INFLUENZA VIRUS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID | Sirna Therapeutics, Inc. (US) | 2008-08-06 | — | — | EP | disclosed |
| EP-1931781-A2 | CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE | Sirna Therapeutics, Inc. (US) | 2008-06-18 | — | — | EP | disclosed |
| WO-2008030239-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF HISTONE DEACETYLASE (HDAC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2008-03-13 | — | — | WO | disclosed |
| EP-1891217-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | Sirna Therapeutics, Inc. (US) | 2008-02-27 | — | — | EP | disclosed |
| WO-2008011467-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF STEROL REGULATORY ELEMENT-BINDING PROTEIN 1 (SREBP1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| WO-2007120527-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS INC. (US) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007092059-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF INFLUENZA VIRUS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID | SIRNA THERAPEUTICS, INC. (US) | 2007-08-16 | — | — | WO | disclosed |
| WO-2007084865-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
| WO-2007022369-A2 | CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID MOLECULES THAT MEDIATE RNA INTERFERENCE | SIRNA THERAPEUTICS, INC. (US) | 2007-02-22 | — | — | WO | disclosed |
| WO-2006128141-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | SIRNA THERAPEUTICS, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1675949-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | Sirna Therapeutics, Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| WO-2005045035-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005014811-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| WO-2005007855-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| WO-2004111237-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR (ECGF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | SIRNA THERAPEUTICS, INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004097020-A2 | RNA INTERFERENCE MEDIATED INHIBITION OF MAP KINASE GENE EXPRESSION | SIRNA THERAPEUTICS, INC. (US) | 2004-11-11 | — | — | WO | disclosed |